Nicholas K Hayward

Nicholas K Hayward

UNVERIFIED PROFILE

Are you Nicholas K Hayward?   Register this Author

Register author
Nicholas K Hayward

Nicholas K Hayward

Publications by authors named "Nicholas K Hayward"

Are you Nicholas K Hayward?   Register this Author

100Publications

4349Reads

28Profile Views

Germline variants in oculocutaneous albinism genes and predisposition to familial cutaneous melanoma.

Pigment Cell Melanoma Res 2019 Nov 6;32(6):854-863. Epub 2019 Jul 6.

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12804DOI Listing
November 2019

as a candidate high-penetrance melanoma susceptibility gene.

J Med Genet 2019 Nov 8. Epub 2019 Nov 8.

Dermatology, Leids Universitair Medisch Centrum, Leiden, Zuid-Holland, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2019-106134DOI Listing
November 2019

Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.

Cell Rep 2019 Oct;29(3):573-588.e7

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94158, USA; Department of Dermatology, University of California, San Francisco, San Francisco, CA 94115, USA; Department of Pathology, University of California, San Francisco, San Francisco, CA 94115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2019.09.009DOI Listing
October 2019

Molecular Genomic Profiling of Melanocytic Nevi.

J Invest Dermatol 2019 Aug 14;139(8):1762-1768. Epub 2019 Feb 14.

Melanoma Institute Australia, The University of Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0022202X193011
Publisher Site
http://dx.doi.org/10.1016/j.jid.2018.12.033DOI Listing
August 2019

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

J Natl Cancer Inst 2018 12;110(12):1328-1341

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292796PMC
December 2018

Proteomic phenotyping of metastatic melanoma reveals putative signatures of MEK inhibitor response and prognosis.

Br J Cancer 2018 09 17;119(6):713-723. Epub 2018 Aug 17.

Australian Proteome Analysis Facility (APAF), Department of Chemistry & Biomolecular Sciences, Macquarie University, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0227-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173697PMC
September 2018

UVB represses melanocyte cell migration and acts through β-catenin.

Exp Dermatol 2017 10 3;26(10):875-882. Epub 2017 May 3.

Institut Curie, PSL Research University, INSERM U1021, Normal and Pathological Development of Melanocytes, Orsay, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/exd.13318DOI Listing
October 2017

Promoter Mutations Ablate GABP Transcription Factor Binding in Melanoma.

Cancer Res 2017 04 20;77(7):1649-1661. Epub 2017 Jan 20.

Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-0919DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711603PMC
April 2017

Mutation load in melanoma is affected by MC1R genotype.

Pigment Cell Melanoma Res 2017 03 7;30(2):255-258. Epub 2017 Mar 7.

QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pcmr.12571
Publisher Site
http://dx.doi.org/10.1111/pcmr.12571DOI Listing
March 2017

Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.

Lab Invest 2017 02 9;97(2):130-145. Epub 2017 Jan 9.

Melanoma Institute Australia, The University of Sydney, North Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/labinvest.2016.143DOI Listing
February 2017

Increased incidence of bladder cancer, lymphoid leukaemia, and myeloma in a cohort of Queensland melanoma families.

Fam Cancer 2016 10;15(4):651-63

QIMR Berghofer Medical Research Institute, PO Royal Brisbane Hospital, Herston, Brisbane, QLD, 4029, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-016-9907-3DOI Listing
October 2016

Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.

Int J Cancer 2016 08 4;139(3):664-72. Epub 2016 Apr 4.

The University of Queensland Diamantina Institute, Translational Research Institute, Woolloongabba, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30085DOI Listing
August 2016

The genomic landscape of cutaneous melanoma.

Pigment Cell Melanoma Res 2016 May 4;29(3):266-83. Epub 2016 Mar 4.

Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Qld, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12459DOI Listing
May 2016

A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.

Cell Rep 2016 05 19;15(9):1884-92. Epub 2016 May 19.

Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.04.072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4889472PMC
May 2016

Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.

Carcinogenesis 2016 Apr 10;37(4):356-65. Epub 2016 Feb 10.

Surgical Oncology Group, School of Medicine, The University of Queensland, Translational Research Institute at the Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland 4102, Australia, Department of Surgery, School of Medicine, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Brisbane, Queensland 4102, Australia and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgw018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806711PMC
April 2016

Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.

Pathology 2016 Apr 9;48(3):261-6. Epub 2016 Mar 9.

Melanoma Institute Australia, North Sydney, NSW, Australia; Discipline of Pathology, Sydney Medical School, The University of Sydney, NSW, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2016.01.001DOI Listing
April 2016

Melanoma genetics.

J Med Genet 2016 Jan 3;53(1):1-14. Epub 2015 Sep 3.

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2015-103150DOI Listing
January 2016

Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.

Pathology 2015 Dec;47(7):683-93

1Melanoma Institute Australia, North Sydney, NSW 2Sydney Medical School, The University of Sydney, Camperdown, NSW 3Immunogenomics Laboratory, Australian National University, Canberra, ACT 4Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld 5Centre for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead, NSW 6Bioplatforms Australia, Macquarie University, North Ryde, NSW 7Ludwig Institute for Cancer Research, Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic 8The Cancer Development and Treatment Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Vic 9Departments of Melanoma and Surgical Oncology 10Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; these authors contributed equally.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0000000000000324DOI Listing
December 2015

Exome Sequencing to Predict Neoantigens in Melanoma.

Cancer Immunol Res 2015 Sep 5;3(9):992-8. Epub 2015 Jun 5.

Cancer Immunotherapy, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0088DOI Listing
September 2015

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.

Nat Genet 2015 Sep 3;47(9):987-995. Epub 2015 Aug 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.3373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557485PMC
September 2015

Germline RAD51B truncating mutation in a family with cutaneous melanoma.

Fam Cancer 2015 Jun;14(2):337-40

Department of Clinical Genetics, Rigshospitalet, 4062, Blegdamsvej 9, 2100, Copenhagen, Denmark,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10689-015-9781-4DOI Listing
June 2015

PARP1 polymorphisms play opposing roles in melanoma occurrence and survival.

Int J Cancer 2015 May 6;136(10):2488-9. Epub 2014 Nov 6.

Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29280DOI Listing
May 2015

MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.

Pigment Cell Melanoma Res 2015 May 5;28(3):254-66. Epub 2015 Jan 5.

Westmead Millennium Institute, The University of Sydney, Sydney, NSW, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12343DOI Listing
May 2015

Exploration of peptides bound to MHC class I molecules in melanoma.

Pigment Cell Melanoma Res 2015 May 5;28(3):281-94. Epub 2015 Mar 5.

Oncogenomics Research Group, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Qld, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12357DOI Listing
May 2015

Genetics of familial melanoma: 20 years after CDKN2A.

Pigment Cell Melanoma Res 2015 Mar 5;28(2):148-60. Epub 2015 Jan 5.

QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia; University of Queensland, Brisbane, Qld, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12333DOI Listing
March 2015

Histologic features of melanoma associated with CDKN2A genotype.

J Am Acad Dermatol 2015 Mar 13;72(3):496-507.e7. Epub 2015 Jan 13.

Department of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.11.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333073PMC
March 2015

Telomere-regulating genes and the telomere interactome in familial cancers.

Mol Cancer Res 2015 Feb 22;13(2):211-22. Epub 2014 Sep 22.

Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278843PMC
February 2015

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

J Natl Cancer Inst 2015 Feb 13;107(2). Epub 2014 Dec 13.

Affiliations of authors: QIMR Berghofer Medical Research Institute, Brisbane, Australia (LGA, ALP, MG, PJ, JMP, JS, VB, SW, KDR, MSS, GWM, NGM, NKH); Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK (CDRE, TMK, DJA); Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark (KW, AMG); Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK (MH, HSn, DTB, JANB); Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (JC, KMB); Departamento de Bioquímica y Biología Molecular, Instituto Universitario de Oncología del Principado de Asturias (IUOPA) Universidad de Oviedo, Oviedo, Spain (VQ, AJR, CLO); Cancer Genomics Research Laboratory, NCI Frederick, SAIC-Frederick Inc., Frederick MD (XZ, KJ); Department of Dermatology, Leiden University Medical Centre, Leiden, the Netherlands (RvD, NAG); Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, Lund, Sweden (HO, CI, ÅB, GJ); Translational Genomics Institute, Phoenix, AZ (JMT); University of Sydney at Westmead Millennium Institute, Westmead, Sydney, NSW, Australia (EAH, HSc, GJM); Melanoma Institute Australia, North Sydney, NSW, Australia (EAH, HSc, GJM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334787PMC
February 2015

Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma.

Nat Commun 2014 Dec 2;5:5694. Epub 2014 Dec 2.

1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6694DOI Listing
December 2014

The effect on melanoma risk of genes previously associated with telomere length.

J Natl Cancer Inst 2014 Oct 17;106(10). Epub 2014 Sep 17.

Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, Leeds Cancer Research UK Centre, University of Leeds, Leeds, UK (MMI, DTB, JCT, MHa, JRM, JANB, JHB); Oncogenomics (NKH), Genetic Epidemiology (NGM), Inflammatory Bowel Diseases Laboratory (GLRS), Cancer Control Group (DCW), Statistical Genetics (SM, MHL), and Molecular Epidemiology (GWM), QIMR Berghofer Medical Research Institute, Brisbane, Australia; INSERM, UMR-946, Genetic Variation and Human Diseases Unit, Paris, France (MB, FD); Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France (MB, FD); Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Australia (AEC); Department of Oncology, University of Cambridge, Cambridge, UK (AMD, PDPP); Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX (JEL); Centre for Genetic Origins of Health and Disease, Faculty of Medicine, Dentistry and Health Sciences, University of Western Australia, Crawley, Australia (EKM, SVW); Centre for Cancer Biomarkers CCBIO (LAA) and Gade Laboratory for Pathology (AM), Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Pathology, Haukeland University Hospital, Bergen, Norway (LAA); Department of Pathology, Molecular Pathology (PAA) and Department of Dermatology (PH), Oslo University Hospital, Rikshospitalet, Oslo, Norway; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Dermatologie, Université Paris Descartes, Paris, France (MFA); Department of Dermatology (EA) and Oncogenics Unit (EA, EF), Sheba Medical Center, Tel Hashomer, Sackler Faculty of Medicine, Tel Aviv, Israel (EA); Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy (GBS, EFPG); Laboratory of Genetics of Rare Hereditary Cancers, San Martino-IST Research Hospital, Genoa, Italy (GBS, EFPG); Division of Cancer Epidemiology and Gene

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/IlesMM_JNCI_EPUB
Web Search
http://jnci.oxfordjournals.org/cgi/doi/10.1093/jnci/dju267
Publisher Site
http://dx.doi.org/10.1093/jnci/dju267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196080PMC
October 2014

Identification of a melanoma susceptibility locus and somatic mutation in TET2.

Carcinogenesis 2014 Sep 30;35(9):2097-101. Epub 2014 Jun 30.

Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146422PMC
September 2014

Prognostic value of BRAF mutations in localized cutaneous melanoma.

J Am Acad Dermatol 2014 May 2;70(5):858-62.e1-2. Epub 2014 Jan 2.

Genetics and Computational Biology Department, Queensland Institute of Medical Research, Brisbane, Australia; Center for Research Excellence in Sun and Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2013.10.064DOI Listing
May 2014

A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers.

PLoS One 2013 19;8(8):e72144. Epub 2013 Aug 19.

Oncogenomics Laboratory, Queensland Institute of Medical Research, Brisbane, Queensland, Australia ; University of Queensland, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0072144PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747051PMC
April 2014

The effect of MC1R variants and sunscreen on the response of human melanocytes in vivo to ultraviolet radiation and implications for melanoma.

Pigment Cell Melanoma Res 2013 Nov 9;26(6):835-44. Epub 2013 Sep 9.

Centre for Research Excellence in Sun and Health, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Qld, Australia; Genetics & Population Health Division, QIMR Berghofer Medical Research Institute, Brisbane, Qld, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12157DOI Listing
November 2013

SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis.

Cancer Res 2013 Sep 1;73(18):5709-18. Epub 2013 Aug 1.

Authors' Affiliations: Genetic Disease Research Branch, National Human Genome Research Institute, Bethesda, Maryland; Maryland Melanoma Center at Medstar Franklin Square Medical Center, Baltimore, Maryland; Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; Queensland Institute of Medical Research, Oncogenomics Laboratory, Brisbane, Australia; and Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-4620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3803156PMC
September 2013

The risk of Barrett's esophagus associated with abdominal obesity in males and females.

Int J Cancer 2013 May 30;132(9):2192-9. Epub 2012 Oct 30.

Cancer Program, Queensland Institute of Medical Research, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27887DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180019PMC
May 2013

Molecular pathways: mitogen-activated protein kinase pathway mutations and drug resistance.

Clin Cancer Res 2013 May 13;19(9):2301-9. Epub 2013 Feb 13.

Oncogenomics Research Group, CBCRC Building, Queensland Institute of Medical Research, Herston, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0383DOI Listing
May 2013

NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.

J Invest Dermatol 2013 Apr 25;133(4):1027-33. Epub 2012 Oct 25.

Genetics and Computational Biology Department, Queensland Institute of Medical Research, Brisbane, Queensland, Australia .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2012.385DOI Listing
April 2013

A variant in FTO shows association with melanoma risk not due to BMI.

Nat Genet 2013 Apr 3;45(4):428-32, 432e1. Epub 2013 Mar 3.

Section of Epidemiology and Biostatistics, Leeds Institute of Molecular Medicine, Leeds Cancer Research UK Centre, St. James's University Hospital, Leeds, UK.

View Article

Download full-text PDF

Source
https://genepi.qimr.edu.au/contents/p/staff/Iles_etal_Nature
Web Search
http://www.nature.com/doifinder/10.1038/ng.2571
Publisher Site
http://dx.doi.org/10.1038/ng.2571DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640814PMC
April 2013

Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases.

Pigment Cell Melanoma Res 2013 Mar 11;26(2):278-9. Epub 2012 Dec 11.

Oncogenomics Laboratory, Queensland Institute of Medical Research, Brisbane, QLD, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12046DOI Listing
March 2013

Whole genome and exome sequencing of melanoma: a step toward personalized targeted therapy.

Adv Pharmacol 2012 ;65:399-435

Queensland Institute of Medical Research, Oncogenomics Laboratory, Brisbane QLD 4006, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-397927-8.00013-0DOI Listing
February 2013

A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma.

Pigment Cell Melanoma Res 2012 Nov 1;25(6):815-8. Epub 2012 Oct 1.

Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pcmr.12006DOI Listing
November 2012